| Ident. | Authors (with country if any) | Title |
|---|
| 001573 |
C. Gargalidis-Moudanos [France] ; N. Pizzinat ; F. Javoy-Agid ; A. Remaury ; A. Parini | I2-imidazoline binding sites and monoamine oxidase activity in human postmortem brain from patients with Parkinson's disease |
| 001578 |
S. Vyas [France] ; F. Javoy-Agid [France] ; M.-T. Herrero [Espagne] ; O. Strada [France] ; F. Boissiere [France] ; U. Hibner [France] ; Yves Agid [France] | Expression of Bcl-2 in adult human brain regions with special reference to neurodegenerative disorders |
| 001633 |
J. Guridi [Espagne] ; M. T. Herrero ; M. R. Luquin ; J. Guillen ; M. Ruberg ; J. Laguna ; M. Vila ; F. Javoy-Agid ; Yves Agid [France] ; E. Hirsch ; J. A. Obeso | Subthalamotomy in parkinsonian monkeys : Behavioural and biochemical analysis |
| 001712 |
P. Anglade [France] ; S. Tsuji [France] ; F. Javoy-Agid [France] ; Yves Agid [France] ; E. C. Hirsch [France] | Plasticity of nerve afferents to nigrostriatal neurons in Parkinson's disease |
| 001722 |
V. Blanchard [France] ; M. Chritin ; SHEELA VYAS [France] ; M. Savasta ; C. Feuerstein ; Yves Agid [France] ; F. Javoy-Agid [France] ; R. Raisman-Vozari [France] | Long-term induction of tyrosine hydroxylase expression : compensatory response to partial degeneration of the dopaminergic nigrostriatal system in the rat brain |
| 001729 |
M.-T. Herrero [Espagne] ; S. J. Augood ; E. C. Hirsch [France] ; F. Javoy-Agid [France] ; M. R. Luquin [Espagne] ; Yves Agid [France] ; J. A. Obeso [Espagne] ; P. C. Emson | Effects of L-DOPA on preproenkephalin and preprotackykinin gene expression in the MPTP-treated monkey striatum |
| 001731 |
M. Ruberg [France] ; D. Scherman [France] ; F. Javoy-Agid [France] ; Yves Agid [France] | Dopamine denervation, age on onset, and Parkinson's disease |
| 001739 |
B. A. Faucheux [France] ; M. T. Herrero ; J. Villares [France] ; R. Levy [France] ; F. Javoy-Agid [France] ; J. A. Obeso ; J. J. Hauw [France] ; Yves Agid [France] ; E. C. Hirsch [France] | Autoradiographic localization and density of[125I]ferrotransferrin binding sites in the basal ganglia of control subjects, patients with Parkinson's disease and MPTP-lesioned monkeys |
| 001783 |
S. Holemans [Belgique] ; F. Javoy-Agid [France] ; Yves Agid [France] ; F. De Paermentier ; E. C. Laterre [Belgique] ; J.-M. Maloteaux [Belgique] | Sulfonylurea binding sites in normal human brain and in Parkinson's disease, progressive supranuclear palsy and Huntington's disease |
| 001794 |
S. Lehericy [France] ; J.-P. Brandel [France] ; E. C. Hirsch [France] ; P. Anglade [France] ; J. Villares [France] ; D. Scherman [France] ; C. Duyckaerts [France] ; F. Javoy-Agid [France] ; Yves Agid [France] | Monoamine vesicular uptake sites in patients with Parkinson's disease and Alzheimer's disease, as measured by tritiated dihydrotetrabenazine autoradiography |
| 001796 |
J. Villares [France] ; O. Strada ; B. Faucheux ; F. Javoy-Agid ; Yves Agid [France] ; E. C. Hirsch | Loss of striatal affinity NGF binding sites in progressive supranuclear palsy but not in Parkinson's disease |
| 001800 |
G. Boka [France] ; P. Anglade [France] ; D. Wallach ; F. Javoy-Agid [France] ; Yves Agid [France] ; E. C. Hirsch [France] | Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease |
| 001808 |
A. Kastner [France] ; M. T. Herrero [France] ; E. C. Hirsch [France] ; J. Guillen ; M. R. Luquin ; F. Javoy-Agid [France] ; J. A. Obeso ; Yves Agid [France] | Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP-intoxicated monkeys : effect of levodopa and GM1 ganglioside therpay |
| 001856 |
A. Kastner [France] ; E. C. Hirsch ; Yves Agid [France] ; F. Javoy-Agid | Tyrosine hydroxylase protein and messenger RNA in the dopaminergic nigral neurons of patients with Parkinson's disease |
| 001871 |
O. Strada [France] ; E. C. Hirsch [France] ; F. Javoy-Agid [France] ; C. Duyckaerts [France] ; J.-J. Hauw [France] ; Yves Agid [France] | Low affinity nerve growth factor receptor, adrenal transplant and Parkinson's disease |
| 001876 |
A. Kastner [France] ; E. C. Hirsch ; M. T. Herrero ; F. Javoy-Agid ; Yves Agid [France] | Immunocytochemical quantification of tyrosine hydroxylase at a cellular level in the mesencephalon of control subjects and patients with Parkinson's and Alzheimer's disease |
| 001877 |
P. Damier [France] ; E. C. Hirsch ; P. Zhang ; Yves Agid [France] ; F. Javoy-Agid | Glutathione peroxidase, glial cells and Parkinson's disease |
| 001878 |
M.-T. Herrero [France] ; A. Kastner [France] ; I. Perez-Otano ; E. C. Hirsch [France] ; M.-R. Luquin ; F. Javoy-Agid [France] ; J. Del Rio ; J. A. Obeso ; Yves Agid [France] | Gangliosides and parkinsonism |
| 001888 |
M. T. Herrero [France] ; E. C. Hirsch [France] ; A. Kastner [France] ; M. Ruberg [France] ; M. R. Luquin ; J. Laguna ; F. Javoy-Agid [France] ; J. A. Obeso ; Yves Agid [France] | Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP ? |
| 001889 |
B. A. Faucheux [France] ; E. C. Hirsch [France] ; J. Villares [France] ; F. Selimi [France] ; A. Mouatt-Prigent [France] ; F. Javoy-Agid [France] ; J. J. Hauw [France] ; Yves Agid [France] | Distribution of 125I-ferrotransferrin binding sites in the mesencephalon of control subjects and patients with Parkinson's disease |
| 001890 |
M. T. Herrero [France] ; E. C. Hirsch [France] ; F. Javoy-Agid [France] ; J. A. Obeso ; Yves Agid [France] | Differential vulnerability to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine of dopaminergic and cholinergic neurons in the monkey mesopontine tegmentum |
| 001892 |
P. Vermersch [France] ; A. Delacourte [France] ; F. Javoy-Agid [France] ; J.-J. Hauw [France] ; Yves Agid [France] | Dementia in Parkinson's disease : biochemical evidence for cortical involvement using the immunodetection of abnormal Tau proteins |
| 001895 |
J. Villares [France] ; B. Faucheux ; O. Strada ; E. C. Hirsch ; Yves Agid [France] ; F. Javoy-Agid | Autoradiographic study of [125I]epidermal growth factor-binding sites in the mesencephalon of control and parkinsonian brains post-mortem |
| 001896 |
Yves Agid [France] ; M. Ruberg ; F. Javoy-Agid ; E. Hirsch ; R. Raisman-Vozari ; S. Vyas ; B. Faucheux ; P. Michel ; A. Kastner ; V. Blanchard ; P. Damier ; J. Villares ; PING ZHANG | Are dopaminergic neurons selectively vulnerable to Parkinson's disease ? |
| 001954 |
A. Kastner [France] ; E. C. Hirsch ; O. Lejeune ; F. Javoy-Agid ; O. Rascol [France] ; Yves Agid [France] | Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content ? |
| 001958 |
E. C. Hirsch [France] ; A. Mouatt ; B. Faucheux ; A.-M. Bonnet ; F. Javoy-Agid ; A. M. Graybiel ; Yves Agid [France] | Dopamine, tremor, and Parkison's disease |
| 001A09 |
E. C. Hirsch [France] ; J.-P. Brandel ; P. Galle ; F. Javoy-Agid ; Yves Agid [France] | Iron and aluminium increase in the substantia nigra of patients with Parkinson's disease : an X-ray microanalysis |
| 001A10 |
G. K. Lloyd [France] ; A. Lowenthal ; F. Javoy-Agid ; J. Constantidinis | GABAA receptor complex function in frontal cortex membranes from control and neurological patients |
| 001A20 |
P. Gaspar [France] ; C. Duyckaerts [France] ; C. Alvarez ; F. Javoy-Agid ; B. Berger | Alterations of dopaminergic and noradrenergic innervations in motor cortex in Parkinson's disease |
| 001A56 |
E. C. Hirsch ; C. Duyckaerts ; F. Javoy-Agid ; J.-J. Hauw ; Yves Agid [France] | Does adrenal graft enhance recovery of dopaminergic neurons in Parkinson's disease ? |
| 001A93 |
D. Scherman ; C. Desnos ; F. Darchen ; P. Pollak ; F. Javoy-Agid ; Yves Agid [France] | Striatal dopamine deficiency in Parkinson's disease: role of aging |
| 001B22 |
J. Epelbaum ; F. Javoy-Agid ; A. Enjalbert ; S. Krantic ; C. Kordon ; Yves Agid [France] | Somatostatin concentrations and binding sites in human frontal cortex are differentially affected in Parkinson's disease associated dementia and in progressive supranuclear palsy |
| 001B24 |
S. Jegou ; F. Javoy-Agid ; C. Delbende ; D. Tranchand-Bunel ; D. H. Coy ; Yves Agid [France] ; H. Vaudry | Regional distribution of vasoactive intestinal peptide in brains from normal and parkinsonian subjects |
| 001B29 |
L. Pierot ; C. Desnos ; J. Blin ; R. Raisman ; D. Scherman ; F. Javoy-Agid ; M. Ruberg ; Yves Agid [France] | D1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsy |
| 001B52 |
P. Dealy-Goyet ; J.-M. Zajac ; F. Javoy-Agid ; Yves Agid [France] ; B. P. Roques | Regional distribution of μ, σ and k opioid receptors in human brains from controls and parkinsonian subjects |
| 001B55 |
R. Cash ; T. Dennis ; R. L'Heureux ; R. Raisman ; F. Javoy-Agid ; B. Scatton | Parkinsons disease and dementia: norepinephrine and dopamine in locus ceruleus |
| 001B56 |
E. C. Hirsch ; A. M. Graybiel ; C. Duyckaerts ; F. Javoy-Agid | Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy |
| 001B67 |
J. Epelbaum ; F. Javoy-Agid ; E. Hirsch ; J. J. Hauw ; C. Kordon ; S. Krantic ; Yves Agid [France] | Brain somatostatin concentrations do not decrease in progressive supranuclear palsy |
| 001B77 |
Yves Agid [France] ; H. Taquet ; F. Cesselin ; J. Epelbaum ; F. Javoy-Agid | Neuropeptides and parkinson's disease |
| 001B82 |
B. Scatton ; T. Dennis ; R. L'Heureux ; J.-C. Monfort ; C. Duyckaerts ; F. Javoy-Agid | Degeneration of noradrenergic and serotonergic but not dopaminergic neurones in the lumbar spinal cord of parkinsonian patients |
| 001B96 |
J. C. Monfort ; F. Javoy-Agid ; J. J. Hauw ; B. Dubois ; Yves Agid [France] | Brain glutamate decarboxylase in Parkinson's disease with particular reference to a premortem severity index |
| 001C01 |
B. Bokobza ; M. Ruberg ; B. Scatton ; F. Javoy-Agid ; Yves Agid [France] | [3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy |
| 001C04 |
C. Llorens-Cortes ; F. Javoy-Agid ; Yves Agid [France] ; H. Taquet ; J. C. Schwartz | Enkephalinergic markers in substantia nigra and caudate nucleus from Parkinsonian subjects |
